Basic Information
Basic information for SNHG11-222-17aa
Peptide Name SNHG11-222-17aa
Genome Position chr20:38448707-38448730,38450336-38450362[+]
Species Human
Peptide Sequence MLDLSILEGCCLGSGNC
Peptide Length 17
Unique No (SNHG11-201-17aa,SNHG11-203-17aa-1,SNHG11-204-17aa,SNHG11-205-17aa,SNHG11-206-17aa,SNHG11-209-17aa,SNHG11-210-17aa,SNHG11-214-17aa,SNHG11-215-17aa-2,SNHG11-218-17aa,SNHG11-221-17aa-2,SNHG11-224-17aa,SNHG11-225-17aa-2,SNHG11-226-17aa-2,SNHG11-230-17aa,SNHG11-232-17aa,SNHG11-234-17aa,SNHG11-236-17aa-2,SNHG11-238-17aa,SNHG11-239-17aa)
Grand Average of Hydropathicity 0.9294
Relative Molecular Mass 2016.28
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000174365;SNHG11
Transcript ID/Name ENST00000659148;SNHG11-222
Transcript Length 1073
Coding Ability 0.4231
DNA Sequence Corresponding to Peptide ATGCTAGACCTCAGTATCCTTGAGGGATGCTGCCTTGGGTCTGGAAACTGT
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :